Unconfigured Ad

Collapse

Application of sequencing to RNA analysis (RNA-Seq, whole transcriptome, SAGE, expression analysis, novel organism mining, splice variants)

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by jgoecks, 11-29-2010, 02:06 PM
27 responses
75,796 views
0 reactions
Last Post suparmin  
Started by lilian619, 10-26-2010, 11:21 PM
6 responses
2,743 views
0 reactions
Last Post mnkyboy
by mnkyboy
 
Started by Kaisee, 10-28-2010, 12:59 PM
0 responses
2,598 views
0 reactions
Last Post Kaisee
by Kaisee
 
Started by anjana.vr, 10-18-2010, 10:20 AM
1 response
2,961 views
0 reactions
Last Post cavefish  
Started by dror, 10-23-2010, 11:56 PM
5 responses
3,158 views
0 reactions
Last Post dror
by dror
 
Started by daughart, 10-25-2010, 09:51 AM
3 responses
3,713 views
0 reactions
Last Post steven
by steven
 
Started by nimmi, 10-25-2010, 11:28 AM
0 responses
2,174 views
0 reactions
Last Post nimmi
by nimmi
 
Started by laxman, 10-22-2010, 10:42 AM
2 responses
3,863 views
0 reactions
Last Post laxman
by laxman
 
Started by ae_ucla, 10-20-2010, 05:15 PM
1 response
3,186 views
0 reactions
Last Post ae_ucla
by ae_ucla
 
Started by Shruti Madhiwalla, 10-22-2010, 05:33 AM
0 responses
2,297 views
0 reactions
Last Post Shruti Madhiwalla  
Started by sridharacharya, 09-17-2010, 05:41 AM
1 response
3,090 views
0 reactions
Last Post glacerda  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Working...